Moreover, a positive feedback loop exists between CXCL16 and inflammatory factors such as IL-17A and TGF-β, mutually promoting their expression and accelerating carotid atherosclerosis progression via activation of the STAT3 and NF-κB pathways. Here, CXCL16 is linked to carotid atherosclerosis.